Long-Term Study of CartiPRO for Knee Pain Due to Osteoarthritis or Cartilage Damage
NCT: NCT07267793 · RECRUITING
Brief Summary
This clinical trial aims to evaluate and compare the efficacy and safety of CartiPRO, an approved intra-articular atelocollagen injection, versus Synovian injection for the relief of knee pain in patients with knee osteoarthritis. The investigational device is administered intra-articularly, with a second injection given 24 weeks after the first dose. Primary and secondary endpoints include changes in pain scores (VAS), functional assessments (WOMAC, SF-36), and safety evaluations over a 36-week period.
Frequently Asked Questions
What is Long-Term Study of CartiPRO for Knee Pain Due to Osteoarthritis or Cartilage Damage?
Long-Term Study of CartiPRO for Knee Pain Due to Osteoarthritis or Cartilage Damage is a clinical trial registered under NCT07267793. Current status: RECRUITING.
What is the status of NCT07267793?
The current status of NCT07267793 (Long-Term Study of CartiPRO for Knee Pain Due to Osteoarthritis or Cartilage Damage) is: RECRUITING.
When did Long-Term Study of CartiPRO for Knee Pain Due to Osteoarthritis or Cartilage Damage start?
Long-Term Study of CartiPRO for Knee Pain Due to Osteoarthritis or Cartilage Damage started on 2025-07-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.